Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page
- Check3 days agoChange DetectedThe page’s software/display revision label has been updated from v3.5.2 to v3.5.3, reflecting a site release without altering the clinical trial study details.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a new ARIA-related publication entry for gantenerumab in early Alzheimer’s disease with an erratum and updated revision to v3.5.2. Removed the earlier ARIA publication entry with revision v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedWebsite version updated from v3.4.3 to v3.5.0, reflecting deployed updates. No study content changes are indicated.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a versioning label with no change to study details or page functionality.SummaryDifference0.0%

- Check75 days agoChange DetectedMinor backend/UI update from v3.4.1 to v3.4.2 with no changes to study data or core content. The page presentation and information remain the same for users. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedWebsite version updated from v3.4.0 to v3.4.1; no user-facing content changes detected.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.